CALAA-01: Clinical Trials

1 trial of CALAA-01, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow CALAA-01: new trials by email Literature Review of CALAA-01 trials Research Report on CALAA-01

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of CALAA-01 to Treat Solid Tumor Cancers
CALAA-01 - Cancer, Solid Tumor
Phase 1TerminatedCalando Pharmaceuticals242008-05-012013-11-01

Conditions studied

Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Colonic Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Skin Neoplasms (1)  ·  Thyroid Neoplasms (1)

Sponsors

Calando Pharmaceuticals (1)

Countries

United States (1)

Top investigators

Anthony W Tolcher, M.D. (1)  ·  Antoni Ribas, M.D. (1)  ·  Yun Yen, M.D., Ph.D. (1)

Results publications

PMID 20305636